Header Logo

Connection

MOTHAFFAR RIMAWI to Cyclin D1

Back to Details
This is a "connection" page, showing publications MOTHAFFAR RIMAWI has written about Cyclin D1.
MOTHAFFAR RIMAWI
Connection Strength
0.024
Cyclin D1
  1. A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer. Breast Cancer Res Treat. 2011 Oct; 129(3):819-27.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.